Latest news & updates on cancer

Mesenchymal stem cells (MSC) and platelet-rich plasma (PRP) therapy in the treatment of knee osteoarthritis
Feb 2024: Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) therapy have shown potential in treating knee osteoarthritis (KOA) in China. A...
Tumor-Infiltrating Lymphocyte (TIL) Therapy in China
Feb 2024: Tumor-infiltrating lymphocyte (TIL) treatment is a potential method that utilizes the body’s immune system to fight solid tumors. This...
The Role Of Immunotherapy In Lymphoma Treatment – CancerFax
If you’re reading this, you or maybe one of your loved ones is on a journey that no one ever plans to take – the path of facing cancer. We understand...
The Life-Changing Treatment for Blood Cancer Finally Exposed!
Blood cancer is a type of cancer that affects both the blood and bone marrow. It is the fifth most common type of cancer in the world, with around 1.24 million...
Clinical Trials Of CAR T-Cell Therapy In China Has Shown Remarkable Success
2024 has been a game-changer for CAR T-Cell therapy in China! Witness remarkable success stories from clinical trials, explore advancements, and learn about...
A Closer Look At Recent Cancer Clinical Trials In China And New Cancer Drug Approved
This article closely examines cancer clinical trials in China in the past few years, focusing on major findings and areas of progress. It also discusses newly...
NMPA Approves FUCASO: A New Era In The World’s Fight Against Multiple Myeloma!
The overall response rate of this revolutionary cancer therapy named FUCASO is 96%. The NMPA’s approval marks a turning point in China’s fight...
The Inside Scoop on Breast Cancer Treatment Costs in India – A Must-Read Revelation!
Breast cancer accounts for 31% of all cancers diagnosed in Indian women, making it the leading type of cancer. This serious disease must be treated at an early...
How PET CT Scan Is Changing Lives Of Cancer Patients Worldwide?
PET scan is a ray of hope in the fight against cancer. If your doctor suspects the case of cancer, they might use this imaging method for accurate diagnosis....
Getting Cancer Treatment In China Without Breaking The Bank: A Guide For Those Who Need It Most
Free cancer treatment in China is providing hope and healing to people in need. So, if you are unable to opt for cancer treatment for its extensive cost, this...
An Informative Guide On The Whispering Signs And Symptoms Of Multiple Myeloma
Read our guide to learn about the silent indicators of multiple myeloma. Learn to spot them early, so you can make smart choices for your health. Don’t...
A Closer Look At The Various Stages Of Multiple Myeloma
Learn about the different stages and types of multiple myeloma. Find hope and support with information on treatments and coping strategies. This simple guide...
How Diagnostic Imaging Saves Lives in Multiple Myeloma Battle?
Curious about how a medical technique named is saving the lives of multiple myeloma? Read our blog to learn more about this life savior technique! Let’s...
The Key To CAR-T Success Lies In Patient Selection – Are You The Ideal One?
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment?...
Immunotherapy Can Help You Win the Battle Against Multiple Myeloma!
Discover how immunotherapy can be your true friend in beating myeloma! Our blog provides simple insights into the power of immunotherapy for multiple myeloma....
How Stem Cell Transplant Is Reshaping The Future Of Multiple Myeloma Treatment?
Stem cell transplantation is an effective treatment for multiple myeloma, a type of blood cancer. This procedure has shown promising results in improving the...
CAR T Cells Are Reshaping the Future of Cancer Treatment!
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a...
The Role Of Immunotherapy In Lymphoma Treatment
If you’re reading this, you or maybe one of your loved ones is on a journey that no one ever plans to take – the path of facing cancer. We understand...
Ivosidenib is approved by FDA for myelodysplastic syndromes
The Food and Drug Administration approved ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) for adult patients with relapsed or refractory myelodysplastic...
Neoadjuvant/ adjuvant pembrolizumab is approved by the FDA for resectable non-small cell lung cancer
The Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with platinum-containing chemotherapy as neoadjuvant treatment, and with continuation...
Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma
The Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) for the adjuvant treatment of completely resected Stage IIB/C...
Encorafenib with binimetinib is approved by the FDA for treatment of metastatic non-small cell lung cancer with a BRAF V600E mutation
The Food and Drug Administration approved encorafenib (Braftovi, Array BioPharma Inc., a wholly owned subsidiary of Pfizer) with binimetinib (Mektovi, Array...
Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia
The Food and Drug Administration approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older with chronic phase (CP) Ph+ chronic...
New and updated indications are approved by FDA for temozolomide under Project Renewal
The Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence...
Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma
HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) was approved by the Food and Drug Administration as a liver-directed...
Elranatamab-bcmm receives accelerated approval by FDA for multiple myeloma
Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by...
A Deep Dive into CAR T Cell Therapy: How Does It Work?
Discover the science behind CAR T Cell therapy treatment in India! Explore how this revolutionary treatment transforms your immune cells into cancer fighters....
Is CAR T-Cell Therapy Available In India?
Have you ever wondered if there is a powerful way to fight cancer? Now just imagine if one day you found a ray of hope in your fight against cancer, a...
Niraparib and abiraterone acetate plus prednisone is approved by FDA for BRCA-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), with prednisone, for...
Talquetamab-tgvs has received accelerated approval for relapsed or refractory multiple myeloma
The Food and Drug Administration granted accelerated approval to talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) for adults with relapsed or refractory...
Pralsetinib is approved by the FDA for non-small cell lung cancer with RET gene fusions
August 2023: Pralsetinib (Gavreto, Genentech, Inc.) was given regular approval by the Food and Drug Administration for adult patients with metastatic RET...
Trifluridine and tipiracil with bevacizumab is approved by FDA for previously treated metastatic colorectal cancer
The Food and Drug Administration approved trifluridine and tipiracil (LONSURF, Taiho Oncology, Inc.) with bevacizumab, for metastatic colorectal cancer (mCRC)...
Dostarlimab-gxly with chemotherapy is approved by the FDA for endometrial cancer
The Food and Drug Administration approved dostarlimab-gxly (Jemperli, GlaxoSmithKline) with carboplatin and paclitaxel, followed by single-agent...
Quizartinib is approved by the FDA for newly diagnosed acute myeloid leukemia
The Food and Drug Administration approved quizartinib (Vanflyta, Daiichi Sankyo, Inc.) with standard cytarabine and anthracycline induction and cytarabine...
A trial shows that blinatumomab could be used in more ways to treat ALL
BLINCYTO® (blinatumomab) is a prescription medicine used to treat B-cell precursor acute lymphoblastic leukemia (ALL) in patients who still have detectable...
Development and future potential of the BiTE (bispecific T-cell engager) platform
Immuno-oncology is a way to treat cancer by using the body's immune system. BiTE (bispecific T-cell engager) technology is a targeted immuno-oncology platform...
Rare autoimmune disorder myasthenia gravis treated by CAR-T therapy
The modified CAR-T treatment, which stands for chimeric antigen receptor T-cell, was used by scientists. It could reduce myasthenia gravis symptoms for a...
Talazoparib with enzalutamide is approved by FDA for HRR gene-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration approved talazoparib (Talzenna, Pfizer, Inc.) with enzalutamide for homologous recombination repair (HRR) gene-mutated...
Glofitamab-gxbm is approved by FDA for selected relapsed or refractory large B-cell lymphomas
July 2023: The Food and Drug Administration gave accelerated approval to glofitamab-gxbm (Columvi, Genentech, Inc.) for relapsed or refractory diffuse large...
Olaparib with abiraterone and prednisone (or prednisolone) is approved by FDA for BRCA-mutated metastatic castration-resistant prostate cancer
July 2023: The Food and Drug Administration (FDA) approved olaparib (Lynparza, AstraZeneca Pharmaceuticals LP) with abiraterone and prednisone (or...
Epcoritamab-bysp is approved by FDA for relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma
July 2023: The Food and Drug Administration gave accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.) for relapsed or refractory diffuse large...
Companies in Korea takes a step closer in developing home grown CAR T-Cell therapy
Due to high costs, treatments developed by multinational pharmaceutical corporations are difficult for Korean patients to access. As a result, Korean...
Polatuzumab vedotin-piiq is approved by USFDA for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma
For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously...
Omidubicel is approved by USFDA to reduce time to neutrophil recovery and infection in patients with hematologic malignancies
Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) was approved by the Food and Drug Administration for use in adult and paediatric patients (12 years of age and...
Enfortumab vedotin-ejfv with pembrolizumab is approved by USFDA for locally advanced or metastatic urothelial carcinoma
Enfortumab vedotin-ejfv (Padcev, Astellas Pharma) and pembrolizumab (Keytruda, Merck) have been given accelerated approval by the Food and Drug Administration...
Retifanlimab-dlwr is approved by FDA for metastatic or recurrent locally advanced Merkel cell carcinoma
Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent...
Tumor Infiltrating lymphocytes (TIL) Immunotherapy in India
Tumor Infiltrating Lymphocytes (TILs) therapy is an experimental cancer treatment that involves harvesting immune cells known as TILs from a patient's tumor,...
Lesser known facts about esophageal cancer
Esophageal cancer is a type of cancer that affects the esophagus, the muscular tube that connects the throat to the stomach. Here are some lesser-known facts...
Abemaciclib with endocrine therapy is approved by FDA in HER 2 positive breast cancer
The Food and Drug Administration (FDA) approved abemaciclib (Verzenio, Eli Lilly and Company) with endocrine therapy (tamoxifen or an aromatase inhibitor) for...
Sam Neill, “Jurassic Park” actor, has been diagnosed with blood cancer
According to the actor from New Zealand's new biography, he has blood cancer and will require chemotherapy for the rest of his life. But while he unwinds on...
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
The goal of this clinical trial is to study the feasibility and efficacy of anti-MESO antigen receptors (CARs) T cell therapy for relapsed and refractory...
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren’s Syndrome
This research focuses on CAR-T cells killing B cells. Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by chronic inflammation of...
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
This is an open, single-arm, dose-escalation and multiple-dose study to evaluate the safety, tolerability and preliminary effectiveness of B7-H3-targeting...
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed Refractory Non-Hodgkin Lymphoma
This is a single-center, single-arm, open-label study. After meeting the eligibility criteria and enrolling on the trial, patients will undergo leukapheresis...
Clinical trial for the April CAR-T Cell therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma
This is a single arm, open-label, single-center study. This study is indicated for relapsed or refractory BCMA/TACI positive relapsed and/or refractory...
Anti-BCMA CAR T-Cell therapy clinical trials for relapse/refractory Immune thrombocytopenia(R/R ITP)
This is a prospective, single-center, open-label, single-arm study, to evaluate the efficacy and safety of Anti-BCMA chimeric antigen receptor T cell...
Clinical trial recruitment for BALL CAR T-Cell therapy
This is a phase I, open-label, single-arm study conducted in China to evaluate the safety, tolerability, PK, and determine the recommended phase II dose (RP2D)...
Oricell raises additional $45M USD to expand its CAR T-Cell therapy to United States
Oricell is developing a number of CAR-T therapies and antibody candidates for solid tumors. In the Phase I trial presented at ASCO, a group of patients with...
China to open borders for patients travelling for medical treatment
China to open its borders for the first time since COVID pandemic outbreak. Borders will open for all types of visa. Check how to obtain medical visa for...
March month is colorectal cancer awareness month
March month if observed as colorectal cancer awareness month. Colorectal cancer is second most deadly cancer on this planet and early diagnosis is required for...
Peter MacCallum Cancer Centre and Cartherics will collaborate on ovarian cancer CAR-T cell therapy
Peter MacCallum Cancer Centre (Peter Mac) and Cartherics Pty Ltd have entered into a collaborative development programme to develop CAR T Cell therapy for...
New drug for primary bone cancer in children
As per the report published in the Journal of Bone Oncology, researchers from the University of East Anglia’s Norwich Medical School demonstrated, that the...
KITE AND ARCELLX CLOSE AGREEMENT TO CO-DEVELOP AND CO-COMMERCIALIZE LATE-STAGE CLINICAL CART-DDBCMA IN MULTIPLE MYELOMA
SANTA MONICA, Calif. & REDWOOD CITY, Calif.–(BUSINESS WIRE)– Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX),...
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI®(ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
JANUARY 27, 2023—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing...
Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China
SOMERSET, N.J.—JANUARY 2, 2023— Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and...
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma
SHANGHAI, CHINA, February 28, 2023 – JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing,...
JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting
SHANGHAI, CHINA, December 12, 2022 – JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing,...
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients
SHANGHAI, CHINA, November 9, 2022 – JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing,...
JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies
SHANGHAI, CHINA and CAMBRIDGE, MASSACHUSETTS, US, October 27, 2022 – JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology...
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma
SHANGHAI, CHINA, October 10, 2022 – JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing,...
How China is leading the development of CAR T-Cell therapy?
The number of CAR-T therapy trials in China surpassed those in the United States by 2018 as a result of this thriving ecosystem. As of June 2022, Chinese...
Cargo, a cancer drug startup, raises $200 million to combat CAR-T relapse
March 2023: Several types of lymphoma, as well as certain leukaemias and multiple myeloma, can now be effectively treated with CAR-T therapy. Recent studies...
New CAR T-Cell therapy drug in lupus renaissance
Several new drugs and promising therapies, such as chimeric antigen receptor T-cell therapy, have ushered in a “renaissance” for lupus, according...
Perspectives on cancer experiences with oncologist Dr. Willie Goffney
Feb 2023: Check out this tweet from American Cancer Society that shares conversation with Dr. Willie Goffney about perspective on cancer. Tweet says...
Enhertu has been approved in China for patients with HER2-positive metastatic breast cancer
Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with...
Actor Hamsa Nandini Provides an Update One Year After Breast Cancer Treatment
Feb 2023: Hamsa Nandini, who was diagnosed with Grade III Invasive Carcinoma (Breast Cancer) in 2021, has updated her Instagram followers on her health status....
Global cost of cancer projected to exceed $25 Trillion by 2050
Feb 2023: According to data published in JAMA Oncology, the global economic cost of cancers is projected to reach $25,2 trillion in international dollars (INT)...
Can the advance stage cancer can be cured? Check the latest developments
Check how the overall landscape of cancer treatment has changed in last few years. Even advance stage cancers can be effectively treated with latest...
Kite completes acquisition of Tmunity
Press Release Feb 2023: – Kite, a Gilead Company (NASDAQ: GILD), today announced the completion of the previously announced transaction to acquire...
High CR rates are overcome by CD22-directed CAR T-Cell therapy against CD19 relapse in LBCL
Feb 2023: A single-institution phase 1 trial found that the use of CD22-directed chimeric antigen receptor (CAR) T-cell therapy after relapse on CD19-directed...
CAR T-cell treatment provides significant remission rates in clinical trials
Feb 2023: In a Phase III study, a CAR T-cell therapy more than tripled progression-free survival compared with standard care for triple-class exposed multiple...
Novel treatment target for lymphoma patients who relapse after CAR-T therapy
Feb 2023: The results of the trial demonstrated that a novel chimeric antigen receptor T-cell therapy elicited a response in adults with advanced large B-cell...
CT103A, CAR T-cell Therapy, has been designated as an orphan drug by the FDA.
Feb 2023: The FDA has granted orphan drug status to CT103A, an experimental CAR T-cell therapy being developed by IASO Biotherapeutics and Innovent Biologics...
CAR T-cell treatment from IASO Biotherapeutics receives new FDA approval
Feb 2023: IASO Biotherapeutics’ investigational CAR T-cell therapy for relapsed or refractory multiple myeloma (RRMM), CT103A, has received fast track...
Dostarlimab-gxly is approved by FDA for dMMR endometrial cancer
Feb 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) was given FDA approval to treat adult patients with mismatch repair deficient (dMMR) recurrent or...
Sacituzumab govitecan-hziy is approved by FDA for HR-positive breast cancer
Feb 2023: For patients with unresectable locally advanced or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+, or IHC 2+/ISH-) breast...
Elacestrant is approved by FDA for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
Feb 2023: Elacestrant (Orserdu, Stemline Therapeutics, Inc.) has been approved by the Food and Drug Administration (FDA) for postmenopausal women or adult men...
Accelerated approval is granted by FDA to pirtobrutinib for relapsed or refractory mantle cell lymphoma
Feb 2023: Accelerated approval is granted by FDA to pirtobrutinib (Jaypirca, Eli Lilly and Company) for relapsed or refractory mantle cell lymphoma. In BRUIN...
Pembrolizumab is approved by FDA as adjuvant treatment for non-small cell lung cancer
Feb 2023: For stage IB (T2a 4 cm), stage II, or stage IIIA non-small cell lung cancer, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda,...
Zanubrutinib is approved by FDA for chronic lymphocytic leukemia or small lymphocytic lymphoma
Feb 2023: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) is approved by FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). SEQUOIA was...
Accelerated approval is granted by FDA to tucatinib with trastuzumab for colorectal cancer
Feb 2023: Tucatinib (Tukysa, Seagen Inc.) and trastuzumab received accelerated approval from the Food and Drug Administration (FDA) for the treatment of RAS...
Bone marrow transplant in Iran
Bone marrow transplant is one of the services of Cancerfax, which is provided by the best surgeons, along with accommodation, translator, companion nurse, and...
Sheba medical center became the first Israeli facility to receive permission from Medtronic International to train medical professionals on MICRA pacemaker implants.
RAMAT GAN, Israel – June, 2022 – Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last...
Utilization of wearable telehealth technology for remote patient monitoring is validated by new Sheba medical center study
July 2022: Peer-reviewed study analyzes usability of a wearable RPM device, which detected early warning of risk for ABCNO deterioration in 75% of...
Focal HIFU therapy in prostate cancer
  What does local prostate cancer mean? In Liv Hospital Urology Clinic, HIFU is applied as the primary treatment approach in localized prostate cancer,...
AMC opens up CAR T-Cell therapy center in Seoul
Jan 2023: The Asan Medical Center (AMC) opened the first CAR-T cell treatment facility in the country after the government approved health insurance benefits...
Best cancer hospitals in India in 2023
Several notable cancer hospitals in India are known for their superior medical competence and cutting-edge technology. The Tata Memorial Hospital in Mumbai is...
Mosunetuzumab-axgb is granted accelerated approval for relapsed or refractory follicular lymphoma
Jan 2023: Mosunetuzumab-axgb (Lunsumio, Genentech, Inc.), a bispecific CD20-directed CD3 T-cell engager for adult patients with relapsed or refractory...
First adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer is approved by FDA
Jan 2023: The drug nadofaragene firadenovec-vncg (Adstiladrin, Ferring Pharmaceuticals) has been approved by the Food and Drug Administration for adult...
Adagrasib gets accelerated approval for KRAS G12C-mutated NSCLC
Jan 2023: Adagrasib (Krazati, Mirati Therapeutics, Inc.), a RAS GTPase family inhibitor, was given accelerated approval by the Food and Drug Administration...
Atezolizumab is approved by FDA for alveolar soft part sarcoma
Dec 2022: Atezolizumab (Tecentriq, Genentech, Inc.) has been approved by the Food and Drug Administration (FDA) for adult and paediatric patients with...
Olutasidenib is approved by FDA for relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation
Dec 2022: Olutasidenib (Rezlidhia) capsules were approved by the Food and Drug Administration (FDA) for adult patients with relapsed or resistant acute...
New dosing regimen for asparaginase erwinia chrysanthemi (recombinant) is approved by FDA
Dec 2022: A new Monday-Wednesday-Friday dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn has been approved by the Food and Drug...
Mirvetuximab soravtansine-gynx is granted accelerated approval for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal cancer
November 2022: For adult patients who have had one to three prior systemic treatment regimens and have folate receptor alpha (FR) positive, platinum-resistant...
Tremelimumab is approved by FDA in combination with durvalumab and platinum-based chemotherapy for metastatic non-small cell lung cancer
November 2022: The combination of tremelimumab (Imjudo, AstraZeneca Pharmaceuticals), durvalumab (Imfinzi, AstraZeneca Pharmaceuticals), and platinum-based...
Brentuximab vedotin is approved by FDA in combination with chemotherapy for pediatric patients with classical Hodgkin lymphoma
November 2022: The combination of doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide with brentuximab vedotin (Adcetris, Seagen, Inc.) has...
Cemiplimab-rwlc is approved by FDA in combination with platinum-based chemotherapy for non-small cell lung cancer
November 2022: The combination of cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) and platinum-based chemotherapy for adult patients with advanced...
Teclistamab-cqyv is approved by FDA for relapsed or refractory multiple myeloma
November 2022: The first bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager, teclistamab-cqyv (Tecvayli, Janssen Biotech, Inc.), was given...
Tremelimumab is approved by FDA in combination with durvalumab for unresectable hepatocellular carcinoma
November 2022: The Food and Drug Administration approved tremelimumab (Imjudo, AstraZeneca Pharmaceuticals) in combination with durvalumab for adult patients...
Cccelerated approval is granted by FDA to futibatinib for cholangiocarcinoma
November 2022: The Food and Drug Administration granted accelerated approval to futibatinib (Lytgobi, Taiho Oncology, Inc.) for adult patients with previously...
Selpercatinib is approved by FDA for locally advanced or metastatic RET fusion-positive solid tumors
November 2022: Selpercatinib (Retevmo, Eli Lilly and Company) received accelerated approval from the Food and Drug Administration to treat adult patients with...
Sodium thiosulfate is approved by FDA to reduce the risk of ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors
November 2022: In children aged one month and older with localised, non-metastatic solid tumours, the Food and Drug Administration has approved sodium...
Durvalumab is approved for locally advanced or metastatic biliary tract cancer
November 2022: For adult patients with locally advanced or metastatic biliary tract cancer, the Food and Drug Administration has approved durvalumab (Imfinzi,...
Pemigatinib is approved for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement
November 2022: Pemigatinib (Pemazyre, Incyte Corporation) has been licenced by the Food and Drug Administration for use in people with relapsed or refractory...
Ibrutinib is approved for pediatric patients with chronic graft versus host disease, including a new oral suspension
Sept 2022: Ibrutinib (Imbruvica, Pharmacyclics LLC) was approved by the Food and Drug Administration for use in paediatric patients with chronic graft versus...
Bone marrow transplant in Iran
Bone marrow  transplant in Iran Bone marrow transplant is one of the services of Iran medtour, which is provided by the best surgeons, along with...
Tecartus granted European marketing authorization for treatment of relapsed or refractory acute lymphoblastic leukemia
Sept 2022: The European Commission (EC) has authorised Kite’s CAR T-cell therapy Tecartus® (brexucabtagene autoleucel) for the treatment of adult...
CAR T-Cell therapy complications can be predicted by a simple blood test
Sept 2022: The treatment of various tumours has been transformed by cell-based immunotherapy, often known as CAR-T cell therapy. In order to target and combat...
New test to determine whether CAR T-Cell therapy will work for lymphoma patients
Sept 2022: According to a study published in the Journal of Clinical Investigation, an engineer at the University of Houston (UH) may have discovered a...
Claudin 18.2 and its role in advanced gastric cancers
August 2022: The most apical portion of polarised epithelial and endothelial cells contains tight junctions, which are specialised membrane domains. The...
Accelerated approval is granted by FDA to fam-trastuzumab deruxtecan-nxki for HER2-mutant non-small cell lung cancer
August 2022: For adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have a mutation resulting in mesenchymal-epithelial...
Capmatinib is approved for metastatic non-small cell lung cancer
August 2022: For adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have a mutation resulting in mesenchymal-epithelial...
Darolutamide tablets is approved by FDA for metastatic hormone-sensitive prostate cancer
August 2022: Darolutamide (Nubeqa, Bayer HealthCare Pharmaceuticals Inc.) tablets combined with docetaxel were approved by the Food and Drug Administration...
Fam-trastuzumab deruxtecan-nxki is approved by FDA for HER2-low breast cancer
August 2022: For adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH) breast cancer who have received prior chemotherapy in the...
Crizotinib is approved by FDA for ALK-positive inflammatory myofibroblastic tumor
  July 2022: Crizotinib (Xalkori, Pfizer Inc.) was granted approval by the Food and Drug Administration (FDA) for the treatment of adult and paediatric...
A memorandum of understanding (MOU) has been signed by GenScript ProBio to form a strategic partnership with ACT Therapeutics to develop new CAR-T cell therapies
July 2022: On July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation...
CAR T-Cell therapy market will grow at phenomenal rate in next 8 years
July 2022: According to the most recent research conducted by Emergen Research, the global market for CAR T-cells therapy reached a size of USD 1.29...
Stanford researchers modified anti-cancer CAR-T cells so they can be controlled with an oral drug
June 2022: According to the findings of a study that was just recently published by Stanford Medicine in mice, a cancer treatment that makes use of a...
New chimeric agent receptor CAR T-cell therapy showed acceptable safety profile in solid tumors
April 2022: According to preliminary data from a phase I/II clinical trial that was presented during the AACR Annual Meeting 2022, which was held from April...
Korean homegrown CAR T-Cell therapy is on the way
Nov 2021: The first clinical trial of South Korea’s homegrown next-generation chimeric antigen receptor T (CAR-T) cell therapy, which is designed to...
Lisocabtagene maraleucel is approved by FDA for second-line treatment of large B-cell lymphoma
July 2022:  Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) has been approved by the Food and Drug Administration for adult patients with large...
Dabrafenib in combination with trametinib is approved by FDA for unresectable or metastatic solid tumors with BRAF V600E mutation
July 2022: Dabrafenib (Tafinlar, Novartis) and trametinib (Mekinist, Novartis) received accelerated approval from the Food and Drug Administration for the...
All participants in a small cancer trial achieved complete remission.
June 2022: A small study of rectal cancer patients yielded extraordinary results: 100 percent of the individuals were in remission. The results were published...
Tisagenlecleucel is approved by FDA for relapsed or refractory follicular lymphoma
June 2022: After two or more lines of systemic therapy, the FDA awarded tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) expedited approval...
Opdivo in combination with chemotherapy and Opdivo in combination with Yervoy is approved by FDA for first-line esophageal squamous cell carcinoma indications
June 2022: For the first-line therapy of individuals with advanced or metastatic esophageal squamous cell carcinoma (ESCC), the Food and Drug Administration...
Ivosidenib in combination with azacitidine is approved for newly diagnosed acute myeloid leukemia
June 2022: Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) in combination with azacitidine has been approved by the Food and Drug Administration for newly...
Azacitidine is approved by FDA for newly diagnosed juvenile myelomonocytic leukemia
June 2022: The FDA has approved the drug azacitidine (Vidaza, Celgene Corp.) for children with newly diagnosed juvenile myelomonocytic leukaemia (JMML). The...
New treatment identified for low grade and serous ovarian cancer
May 2022: Trametinib may become a new standard of care for recurring, low-grade serous ovarian cancer (Mekinist). According to study findings published in the...
Weight loss is linked to decreased risk of colon and rectal polyps
May 2022: According to study findings published February 1 in the Journal of the National Cancer Institute, overweight or obese adults who lose more than 5...
T-cell therapy for gastric, liver and pancreatic cancer
May 2022: T-cell therapy has begun a vigorous attack on digestive system malignancies, and T-cell immunotherapy has triumphed over refractory tumours like...
FDA approves clinical trial application of specific CAR-NK therapy FT536 in the treatment of solid tumors
May 2022: FDA approves clinical trial application of specific CAR-NK therapy FT536 in the treatment of solid tumours in a CAR-NK clinical trial. The FDA...
Patient experience of CAR T-cell therapy suffering from acute lymphoblastic leukemia
May 2022: Matthew is a 27-year-old patient with Acute Lymphoblastic Leukemia who was diagnosed in 2015. Unfortunately, the standard treatment of chemotherapy...
CAR T-Cell therapy and mantle cell lymphoma (MCL)
Induction therapy followed by stem cell transplant has maintained a role in the treatment of mantle cell lymphoma (MCL), according to James Gerson, MD, who...
Fam-trastuzumab deruxtecan-nxki is approved by FDA for breast cancer
April 2022: Adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen either in the...
Pluvicto is approved by FDA for metastatic castration-resistant prostate cancer
April 2022: The Food and Drug Administration approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., a Novartis...
Pembrolizumab is approved for advanced endometrial carcinoma
April 2022: Pembrolizumab (Keytruda, Merck) was approved by the Food and Drug Administration as a single agent for patients with advanced endometrial...
First LAG-3-Blocking antibody combination, Opdualag™ (nivolumab and relatlimab-rmbw), is approved by FDA for patients with unresectable or metastatic melanoma
April 2022: The US Food and Drug Administration (FDA) has approved Opdualag (nivolumab and relatlimab-rmbw), a new, first-in-class fixed-dose combination of...
JW Therapeutics’ IND is cleared by China NMPA for CAR T-Cell therapy in large B-Cell lymphoma
April 2022: The National Medical Products Administration (NMPA) of China has approved JW Therapeutics’ investigational new drug (IND) application for a...
Can CAR T-Cell manufacturing time be reduced to just one day?
April 2022: Normally, the cell manufacturing procedure for CAR T-cell therapy takes nine to fourteen days; however, researchers at the University of...
CAR T-Cell therapy in solid tumors – A research study
March 2022: Blood vessels are supposed to behave like trees, pouring oxygen into tissues in order for them to flourish and immune cells to clean infections...
CAR T- cell therapy for breast cancer is on the cards
March 2022: According to researchers at the UNC Lineberger Comprehensive Cancer Center, adding a tiny chemical to a treatment process called chimeric antigen...
Childhood leukemia and its treatment
Leukemia in childhood Leukemia is the most common cancer in children and teens, accounting for almost 1 out of 3 cancers. Most childhood leukemias are acute...
CARVYKTI (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, receives U.S. FDA approval for the treatment of adult patients with relapsed or refractory multiple myeloma
March 2022: According to Johnson & Johnson, a therapy developed by the company and its China-based partner Legend Biotech Corp to treat a kind of white...
High Intensity Focused Ultrasound
March 2022: HIFU (High Intensity Focused Ultrasound) is a cutting-edge therapy that uses focused, high-energy ultrasound waves to heat and kill cancerous parts...
CAR-T Cell therapy could be made safer and more widely available with a few adjustments
March 2022: A revolutionary approach to CAR-T Cell therapy has the potential to overturn what has become a medical axiom: that the treatment’s remarkable...
CAR-T therapy, CAR-T technology, what are CAR-T cell immunotherapy ? CAR-T treatment cost, latest CAR-T clinical trial recruitment
March 2022: CAR-T therapy, CAR-T technology, what are CAR-T cell immunotherapy ? CAR-T treatment price, cost, the latest CAR-T clinical trial recruitment...
Olaparib is approved for adjuvant treatment of high-risk early breast cancer
March 2022: The Food and Drug Administration has approved olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) for the adjuvant treatment of adult patients...
Neoadjuvant nivolumab and platinum-doublet chemotherapy is approved for early-stage non-small cell lung cancer
March 2022: In the neoadjuvant setting, the FDA approved nivolumab (Opdivo, Bristol-Myers Squibb Company) in combination with platinum-doublet chemotherapy...
Ciltacabtagene autoleucel is approved for relapsed or refractory multiple myeloma
March 2022: After four or more prior lines of therapy, including a proteasome inhibitor (PI), an immunomodulatory agent (IMiD), and an anti-CD38 monoclonal...
Tebentafusp-tebn is approved for unresectable or metastatic uveal melanoma
March 2022: Tebentafusp-tebn (Kimmtrak, Immunocore Limited), a bispecific gp100 peptide-HLA-directed CD3 T cell engager, has been licenced by the Food and Drug...
Abatacept is approved for prophylaxis of acute graft versus host disease
March 2022: Abatacept (Orencia, Bristol-Myers Squibb Company) has been approved by the Food and Drug Administration for the prevention of acute graft versus...
Study suggest CAR T-Cell therapy effective as first line treatment for high risk large B-cell lymphoma
March 2022: The University of Texas MD Anderson Cancer Center researchers discovered that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR...
Rituximab plus chemotherapy is approved by FDA for pediatric cancer indications
March 2022: The Food and Drug Administration has approved rituximab (Rituxan, Genentech, Inc.) in conjunction with chemotherapy for CD20-positive diffuse...
Darzalex faspro, kyprolis, and dexamethasone is approved by FDA for multiple myeloma
March 2022: Daratumumab + hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen, Inc.) plus dexamethasone have been...
Effectiveness of CAR T-Cell therapy against high risk large B-Cell lymphoma
Dec 2020: The University of Texas MD Anderson Cancer Center researchers discovered that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell...
CAR T-Cell therapy for childhood brain tumor
Dec 2021: CAR T-Cell therapy is at present approved for some forms of leukemia, lymphoma and multiple myeloma. Researchers are now also developed the...
Patient in China achieves complete remission from leukemia after CAR T-Cell therapy
Feb 2022: In China, a patient whose life was on the verge of ending was entirely healed of leukaemia thanks to CAR T-cell therapy, which stimulated the immune...
China-based CAR-T Cell therapy achieves breakthrough clinical trial results
June 2016: Professor Huang He of Zhejiang University’s First Affiliated Hospital presented the outcomes of 10 clinical cases including CAR-T cell...
CAR T-Cell therapy saves leukemia patient in China
Feb 2022: A 12-year-old girl from southwest China’s Chongqing Municipality was saved by an unconventional therapy instead of chemotherapy or...
World Cancer Day 2022
4th Feb 2022: In India, cancer can have serious social and economic effects, typically resulting in family destitution and societal injustice. In this...
Pafolacianine is approved for identifying malignant ovarian cancer lesions
Jan 2022: Pafolacianine (Cytalux, On Target Laboratories, LLC), an optical imaging agent, has been licenced by the Food and Drug Administration for adult...
Sirolimus protein-bound particles is approved for malignant perivascular epithelioid cell tumor
Jan 2022: For adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumours, the Food and Drug...
Pembrolizumab is approved for adjuvant treatment of renal cell carcinoma
Jan 2022: Pembrolizumab (Keytruda, Merck) has been approved by the Food and Drug Administration for the adjuvant treatment of patients with renal cell...
Drugs approved for treatment of liver cancer
Dec 2021: Following drugs are approved as on date for treatment of liver cancer. Please check prescribing information before taking the drug....
Brukinsa zanubrutinib
  Dec 2021: BRUKINSA (Zanubrutrinib) is a prescription drug from BeiGene ltd. BRUKINSA is used to treat adults with Mantle cell lymphoma (MCL),...
Asciminib is approved for Philadelphia chromosome-positive chronic myeloid leukemia
Nov 2021: Asciminib (Scemblix, Novartis AG) was given accelerated approval by the Food and Drug Administration for patients with Philadelphia...
Atezolizumab is approved by FDA as adjuvant treatment for non-small cell lung cancer
Nov 2021: The Food and Drug Administration has approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment in patients with stage II to IIIA...
Pembrolizumab combination is approved by FDA for the first-line treatment of cervical cancer
Nov 2021: Pembrolizumab (Keytruda, Merck) in conjunction with chemotherapy, with or without bevacizumab, has been approved by the Food and Drug Administration...
Abemaciclib is approved by FDA with endocrine therapy for early breast cancer
October 2021: The Food and Drug Administration has approved abemaciclib (Verzenio, Eli Lilly and Company) in combination with endocrine therapy (tamoxifen or...
Brexucabtagene autoleucel is approved by FDA for relapsed or refractory B-cell precursor acute lymphoblastic leukemia
October 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) has been approved by the Food and Drug Administration for adult patients with relapsed or...
Ruxolitinib is approved for chronic graft-versus-host disease
October 2021: After failure of one or two lines of systemic therapy, the Food and Drug Administration approved ruxolitinib (Jakafi, Incyte Corp.) for chronic...
Tisotumab forvedotin-tftv is approved for recurrent or metastatic cervical cancer
October 2021: The FDA has given tisotumab vedotin-tftv (Tivdak, Seagen Inc.), a tissue factor-directed antibody and microtubule inhibitor combination, rapid...
Cabozantinib is approved for differentiated thyroid cancer
October 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) has been approved by the Food and Drug Administration for adult and paediatric patients 12 years of age...
The FDA has given mobocertinib expedited approval for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
September 2021: The FDA granted accelerated approval to mobocertinib (Exkivity, Takeda Pharmaceuticals, Inc.) for adult patients with locally advanced or...
The FDA has approved zanubrutinib for the treatment of Waldenstrom’s macroglobulinemia
September 2021: For adult patients with Waldenström’s macroglobulinemia, the FDA has approved zanubrutinib (Brukinsa, BeiGene) (WM). In ASPEN...
Ivosidenib has been approved by the FDA for advanced or metastatic cholangiocarcinoma
Sept 19, 2021: The Food and Drug Administration approved Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) for adult patients with previously treated, locally...
TECARTUS (brexucabtagene autoleucel) – CAR T treatment for relapsed or refractory mantle cell lymphoma
July 25, 2021: Kite, a Gilead Company (Nasdaq: GILD), today announced that the FDA has granted TecartusTM (brexucabtagene autoleucel, formerly KTE-X19), the...
Nivolumab has been approved by the FDA for use as an adjuvant treatment for urothelial carcinoma
August 2021: Nivolumab (Opdivo, Bristol-Myers Squibb Co.) has been approved by the Food and Drug Administration for the adjuvant treatment of patients with...
Dostarlimab-gxly receives accelerated approval from the FDA for dMMR advanced solid tumours
August 2021: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) was given accelerated approval by the Food and Drug Administration for adult patients with...
Belzutifan has been approved by the FDA for malignancies linked to von Hippel-Lindau disease
August 2021: Belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor, has been approved by the Food and Drug Administration for adult patients with...
The FDA has approved the combination of lenvatinib and pembrolizumab for advanced renal cell carcinoma
August 2021: The combination of lenvatinib (Lenvima, Eisai) and pembrolizumab (Keytruda, Merck) has been approved by the Food and Drug Administration for the...
Pembrolizumab has been approved by the FDA for high-risk early-stage triple-negative breast cancer
August 2021: Pembrolizumab (Keytruda, Merck) was approved by the FDA for high-risk, early-stage triple-negative breast cancer (TNBC) as a neoadjuvant treatment...
Pembrolizumab and lenvatinib have been approved by the FDA for advanced endometrial cancer
August 2021: Pembrolizumab (Keytruda, Merck) in combination with lenvatinib (Lenvima, Eisai) has been approved by the Food and Drug Administration for patients...
The FDA has approved belumosudil for the treatment of chronic graft-versus-host disease
August 2021: After failure of at least two prior lines of systemic therapy, the Food and Drug Administration approved belumosudil (Rezurock, Kadmon...
Daratumumab and hyaluronidase-fihj plus pomalidomide and dexamethasone have been approved by the FDA for the treatment of multiple myeloma
August 2021: Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) have been approved by the Food and Drug Administration in combination...
The FDA has given enfortumab vedotin-ejfv approval for the treatment of locally advanced or metastatic urothelial carcinoma
August 2021: Enfortumab vedotin-ejfv (Padcev, Astellas Pharma US, Inc.), a Nectin-4-directed antibody and microtubule inhibitor combination, has been approved...
FDA has approved asparaginase erwinia chrysanthemi (recombinant) for leukaemia and lymphoma
August 2021: The Food and Drug Administration has approved asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) as part...
Avapritinib has been approved by the FDA for advanced systemic mastocytosis
August 2021: The FDA approved avapritinib (AyvakitTM, Blueprint Medicines Corp.) for adult patients with advanced systemic mastocytosis (AdvSM), which includes...
Infigratinib receives accelerated approval from the FDA for metastatic cholangiocarcinoma
August 2021: Infigratinib (Truseltiq, QED Therapeutics, Inc.), a kinase inhibitor, has been granted accelerated approval by the Food and Drug Administration...
Sotorasib receives accelerated approval from the FDA for KRAS G12C mutant NSCLC
August 2021: The FDA granted accelerated approval to sotorasib (LumakrasTM, Amgen, Inc.), a RAS GTPase family inhibitor, for adult patients with KRAS G12C...
Amivantamab-vmjw receives fast approval from the FDA for metastatic non-small cell lung cancer
August 2021: The FDA granted amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.), a bispecific antibody directed against epidermal growth factor (EGF) and MET...
Nivolumab has been approved by the FDA for resected esophageal or gastroesophageal junction cancer
August 2021: The FDA has approved Nivolumab (Opdivo, Bristol-Myers Squibb Company) for patients with fully resected oesophagus or gastroesophageal junction...
Pembrolizumab receives accelerated approval from the FDA for HER2-positive gastric cancer
August 2021: Pembrolizumab (Keytruda, Merck & Co.) in combination with trastuzumab, fluoropyrimidine-, and platinum-containing chemotherapy has been...
The FDA has granted loncastuximab tesirine-lpyl accelerated approval for large B-cell lymphoma
August 2021: The FDA granted loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA), a CD19-directed antibody and alkylating agent conjugate, accelerated...
Dostarlimab-gxly receives accelerated approval from the FDA for dMMR endometrial cancer.
August 2021: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) received accelerated approval from the Food and Drug Administration for adult patients with...
Nivolumab in addition to chemotherapy is approved by FDA for metastatic gastric cancer and esophageal adenocarcinoma
August 2021: For advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the Food and Drug Administration...
Sacituzumab govitecan receives fast approval from the FDA for advanced urothelial cancer
August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) was given accelerated approval by the Food and Drug Administration for patients with locally...
Sacituzumab govitecan receives FDA approval for triple-negative breast cancer
August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) gained regular FDA clearance for patients with unresectable locally advanced or metastatic...
The FDA has approved idecabtagene vicleucel for the treatment of multiple myeloma
August 2021: The Food and Drug Administration approved idecabtagene vicleucel (Abecma, Bristol Myers Squibb) for the treatment of adult patients with relapsed...
Pembrolizumab has been approved by the FDA for the treatment of esophageal or gastroesophageal junction cancer
August 2021: Pembrolizumab (Keytruda, Merck Sharp & Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy has been approved by...
The FDA has approved relugolix for the treatment of advanced prostate cancer
August 2021: The first oral gonadotropin-releasing hormone (GnRH) receptor antagonist, relugolix (ORGOVYX, Myovant Sciences, Inc.), was approved by the Food...
Tivozanib has been approved by the FDA for the treatment of relapsed or refractory advanced renal cell carcinoma
August 2021: Tivozanib (Fotivda, AVEO Pharmaceuticals, Inc.), a kinase inhibitor, has been approved by the FDA for adult patients with relapsed or refractory...
Lorlatinib has been approved by the FDA for the treatment of metastatic ALK-positive NSCLC.
August 2021: Lorlatinib (Lorbrena, Pfizer Inc.) received regular FDA approval for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours are...
The FDA has granted axicabtagene ciloleucel expedited approval for relapsed or refractory follicular lymphoma.
August 2021: The FDA has given axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) expedited approval for adult patients with relapsed or refractory...
Lorlatinib has been approved by the FDA for the treatment of metastatic ALK-positive NSCLC
August 2021: Lorlatinib (Lorbrena, Pfizer Inc.) received regular FDA approval for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours are...
Melphalan flufenamide receives approval from the FDA for relapsed or refractory multiple myeloma
August 2021: Melphalan flufenamide (Pepaxto, Oncopeptides AB) in combination with dexamethasone has been granted accelerated approval by the Food and Drug...
Cemiplimab-rwlc has been approved by the FDA for non-small cell lung cancer with high PD-L1 expression
August 2021: The FDA approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) for the first-line treatment of patients with advanced non-small cell...
Cemiplimab-rwlc has been approved by the FDA for the treatment of locally progressed and metastatic basal cell carcinoma
August 20, 2021: The FDA has given cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) regular approval for patients with locally advanced basal cell...
The FDA has approved the first targeted therapy for a lung cancer mutation that was previously thought to be drug-resistant.
August 20, 2021: Recently in May, 2021 Lumakras (sotorasib) was approved by the US Food and Drug Administration as the first treatment for adult patients with...
Updated guidelines for food and physical activities
July 2021: The American Cancer Society has modified its cancer preventive diet and physical activity guidelines. A person’s lifetime risk of acquiring or...
Pembrolizumab approved for use in any cancer with a high tumor mutational burden
July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any...
Liver cancer surgery and transplant by Dr. Selvakumar
July 14, 2021: Check out interview of Dr. Selvakumar Naganathan – Clinical Lead – Liver transplantation and HPB surgery, Apollo Hospitals,...
Atezolizumab plus Bevacizumab for treatment of liver cancer
July 13th 2021: A novel medication for people with a kind of liver cancer called hepatocellular carcinoma is available that appears to be better than standard...
Beta Thalassemia and its consideration with COVID-19
July 12th 2021: Beta-thalassemia is an inherited condition caused by mutations in a gene involved in the production of a component of haemoglobin, the protein...
Breyanzi – New CAR T-Cell therapy from BMS
July 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), a novel CD19-directed chimeric antigen receptor (CAR) T cell treatment developed by Bristol Myers...
Easily adoptable methods to improve outcomes in treatment of gastroesophageal cancers
July 9th 2021: During the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021, two scientists from Roswell Park...
More than 12% of newly diagnosed lung cancer patients newer smoked cigarettes – study suggests
July 7th 2021 : Tobacco smoking is the leading cause of lung cancer, accounting for over 80% of all fatalities from the disease. People who do not smoke,...
Colorectal cancer latest screening guidelines
July 6th 2021 : Colorectal cancer is the among most prevalent cause of cancer death in the the world. Regular screening, on the other hand, can detect...
CAR T-Cell therapy for T-cell acute lymphoblastic leukaemia (T-ALL)
June 2021 : As per our resources a hospital in China has developed CAR T-Cell therapy for T-cell acute lymphoblastic leukaemia (T-ALL). The expressing protein...
COVID-19 Vaccine – All that you wanted to know
Dr. Julie Gralow answers queries on COVID-19 vaccine. How can we be sure the vaccines are safe if they were produced and approved in such a short period of...
Cancer Associated with AIDS
Acquired Immonodeficiency syndrome (AIDS) is a potentially life threatening condition caused by Human Immunodeficiency Virus (HIV) and is transmitted from...
Lonsurf is approved by FDA for recurrent, metastatic gastric and gastroesophageal junction adenocarcinoma
Trifluridine/tipiracil tablets (LONSURF, Taiho Pharmaceutical Co., Ltd.) were approved by the Food and Drug Administration on February 22, 2019 for adult...
Pembrolizumab is approved by FDA for adjuvant treatment of melanoma
  On February 15, 2019, pembrolizumab (KEYTRUDA, Merck) was approved by the Food and Drug Administration for the adjuvant treatment of patients with...
Caplacizumab-yhdp approved by FDA
On February 6, 2019, in conjunction with plasma exchange and immunosuppressive treatment, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI,...
Cabozantinib is FDA-approved for hepatocellular carcinoma
  On January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular...
Bone marrow stem cell transplant
Bone marrow transplant Bone marrow transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high...
Saliva test aims to detect HPV throat cancer
A Queensland University of Technology (QUT) researcher is developing a simple saliva test to detect human papillomavirus (HPV) in laryngeal cancer. This is...
Bone marrow transplant in India
Bone marrow transplant in India Bone marrow stem cell transplant in India is performed by some of the leading cancer centres. Till date...
Pabosini plus cetuximab for head and neck cancer treatment with 70% focal reduction
According to the results announced at the 2018 ASCO annual meeting, the CDK4/6 inhibitors pabociclib (Ibrance) and cetuximab (Erbitux) combined treatment of...
Both e-cigarettes and ordinary tobacco are associated with oral cancer
At the 96th Congress of the International Association for Dental Research (IADR), Benjamin Chaffee of the University of California, San Francisco published a...
New ways to fight recurrent head and neck cancer
Even with surgery,  radiotherapy, chemotherapy, and/or gene-targeted therapy (such as cetuximab), the five-year survival rate for locally advanced head and...
Citrus oil may help relieve dry mouth symptoms caused by radiation therapy in head and neck cancer
According to a new study by Stanford University School of Medicine, a compound found in citrus oil may help relieve dry mouth symptoms caused by radiation...
Nivolumab combined with ipilimumab was the first successful treatment for head and neck cancer
In patients with metastatic malignant melanoma, the combination of ipilimumab ( CTLA4 antibody) and programmed death (PD)-1 inhibitor nivolumab can...
Significant discovery: the aggressiveness of brain tumors is related to the enhancement of a gene activity
Scientists at the University of California, San Francisco have discovered a common genetic driver of aggressive meningioma, which can help clinicians detect...
Research progress of rare tumor-head and neck cancer drugs
Compared with other malignant tumors such as non-small cell lung cancer (NSCLC) and breast cancer, head and neck squamous cell carcinoma (HNSCC) is relatively...
Can patients with head and neck cancer enjoy spicy hot pot during proton therapy?
Mr. Xu is a typical Chongqing native. He is naturally spicy and unhappy. Among all the spicy foods, Chongqing spicy hot pot is his favorite. However,...
Gastric acid reflux is actually associated with cervical cancer
People are familiar with the uncomfortable feeling of acid reflux. A recent US study found that gastroesophageal reflux disease (GORD) may increase the risk...
Mobile phone radiation and brain tumors
The California Department of Public Health issued guidelines on cell phone radiation and how to reduce exposure. According to the CBS report, although there is...
The expression of PD-L1 in CTC of patients with head and neck squamous cell carcinoma is associated with prognosis
The University of Athens Strati A et al. reported that whether PD-L1 is overexpressed in circulating tumor cells (CTC) can provide more feasible and important...
What factors affect head and neck cancer surgery doctors turn to palliative care?
The report by Kershena Liao of Baylor College of Medicine in the United States and more fully understand the process of head and neck oncologists considering...
A new method for the treatment of neuroendocrine tumors-peptide receptor radionuclide therapy – PRRT
Neuroendocrine tumors are rare, accounting for less than 1% of all malignant tumors, and most of them occur in the stomach, intestines, and pancreas. The most...
Proton therapy in nasopharyngeal cancer
Experts from CancerFax can assist patients to directly consult with experts in major proton centers to determine the suitability of patients for proton...
The culprit of the recurrence of bladder cancer "MLL gene" has been found
The research team of Shenzhen Hospital collected 37 samples of bladder cancer patients, performed whole exon sequencing and gene editing techniques, and...
Gastrointestinal stromal tumor targeting drug Avapritinib
Gastrointestinal stromal tumor targeting drug Avapritinib (Avapriny, Ayvakit, BLU-285) is approved by USFDA on 9th January, 2020. The drug covers two...
Colon and rectal cancer immunotherapy, colorectal cancer PD-1 / PD-L1 treatment
Colon cancer immunotherapy, rectal cancer immunotherapy, colorectal cancer immunotherapy, colorectal cancer PD-1 / PD-L1 treatment. Seventeen years ago, the...
Targeted treatment of colorectal cancer, BRAF V600E gene mutation targeted therapy of colorectal cancer Braftovi + Erbitux finally achieved positive results
Targeted treatment of colorectal  cancer, BRAF V600E gene mutation targeted therapy of colorectal cancer Braftovi + Erbitux finally achieved positive results...
How to prevent and treat relapsed colorectal cancer?
How to prevent relapse of colorectal cancer, how to treat relapse of  colorectal cancer after surgery? Colorectal cancer is a common malignant tumor,...
Intestinal cancer self-test, how to check intestinal cancer?
Intestinal cancer self-test, how to check intestinal cancer, colorectal cancer screening, rectal cancer check, what check for rectal cancer, what check for...
Immunotherapy clears lesions in advanced colorectal cancer
A meal “eats” colorectal cancer In 2014, 65-year-old Mr. Yang and his wife traveled abroad. During the period, gastrointestinal discomfort and...
A colonoscopy reduces the risk of death by 72% in colorectal cancer
“About 5-6 years ago, we started to see some young patients with  colorectal cancer, including some people in their 20s or 30s, which had never been...
Encyclopedia of medication guide for patients with colorectal cancer
In the past two years, with the deepening of research related to targeting and immunotherapy and genotyping, more and more drugs with good effects and fewer...
A vaccine to prevent colorectal cancer was born, specifically for these people
Medical personnel worldwide are developing new human antigen vaccines, including various types of cancer preventive and therapeutic. Click for details: The...
95% of patients with advanced colorectal cancer will detect MSS, how to treat it?
 Before the start of the article, the first look at science. Understanding of MSI-H, MSS, MSI-L MSS (MicroSatellite stability), microsatellite stability,...
The combination of these three drugs after multi-line resistance of colorectal cancer reduces the risk of death by nearly 50%
BRAF mutations occur in 15% of colorectal patients. There are no targeted drugs approved by the FDA so far, and the prognosis is poor. Among them, BRAF V600E...
2019 colorectal cancer NCCN guidelines
The theme of the 2019 NCCN Annual Meeting is to expand biomarker testing to guide the precise treatment of cancer, as well as new changes to colorectal cancer...
How to choose immunotherapy drugs for colorectal cancer?
Immunotherapy uses drugs to help the body’s own immune system better recognize and destroy cancer cells. Immunotherapy can be used to treat patients...
Chemotherapy or targeted therapy for colorectal cancer
Colorectal cancer is one of the most common malignant tumors. In China, the incidence of colorectal cancer is ranked 4th and 3rd among men and women,...
Recommended healthy diet for cancer patients in 2020
Regular exercise, maintaining a healthy weight, and avoiding tobacco products are all lifestyle choices that help reduce the risk of cancer. Healthy eating is...
Just exercise can reduce the number of cancer cells in cancer patients
In all anti-cancer and anti-cancer science articles, we can see the  importance of exercise. It can not only promote a healthy lifestyle, but also change the...
Obesity and colon cancer
According to a recent study  published in JAMA Oncology, obesity is  associated with an increased risk of early-onset colorectal cancer (CRC) in women. A...
Colon cancer warning signal should never be ignored
According to the CDC, colorectal cancer is the third most common cancer diagnosed in the United States and the second leading cause of cancer death in the...
How to prevent bowel cancer through five simple lifestyles?
Among patients with bowel cancer, nearly half of the cases can be prevented by lifestyle changes. Of the 42,000 people diagnosed each year, 95% are over 50...
Genetic testing may change treatment for this rare intestinal tumor
Appendic cancer is very rare, accounting for less than 1% of gastrointestinal tumors, and there is little scientific data on the disease, which means that the...
Cytokine-mediated obesity stimulates intestinal cancer
A new study describes themechanistic relationship between thecytokine interleukin-1β(IL-1β) and obesity. WhenIL-1βlevels increase in obesity, theactivation...
I have bowel cancer and want to live longer to change my diet
According to a new study by the American Cancer Society, patients with colorectal cancer who eat a healthy diet have a reduced risk of dying from colorectal...
Major discovery: this gene mutation is associated with colon cancer
For many years, doctors have been confused about why colon cancer can develop in people who find nothing on colonoscopy. A new discovery from Oklahoma Medical...
Inflammation causes colorectal cancer because of the loss of this protein
Chronic inflammation is a  predisposing factor for colorectal cancer, which is the third leading cause of cancer-related deaths in the United States. Dr. Anna...
Two kinds of hypoglycemic drugs are very effective in colorectal cancer
Obesity is on the rise worldwide and is related to the incidence of colon cancer , but its mechanism has been a mystery. In a new study, Yale University...
Eat more walnuts to help you stay away from colorectal cancer
Nut-rich diets, such as walnuts, have been shown to play a role in heart health and reducing colorectal cancer. According to a new study, the impact of...
Colorectal cancer screening: the test can be completed in a home kit
The American Cancer Society estimates that more than 97,000 people in the United States will be diagnosed with colorectal cancer this year and will cause...
Aspirin plays an amazing role in the treatment of bowel cancer
In previous studies, researchers have clarified how taking aspirin can help prevent bowel cancer. This study found that analgesics block key processes related...
The risk of colon cancer recurrence after surgery can be accurately predicted
The latest research result, the immune score test, can now more accurately define the disease progression of colon cancer patients. According to an...
More and more anxiety and depression after colorectal cancer are related to these factors
In a study published online on April 6 in Cancer, the prevalence of depression and anxiety increased among patients with colorectal cancer (CRC). The team of...
A single gene detection method can confirm precancerous lesions of colorectal cancer
According to the latest clinical data, a single pre-genome test is more effective for Lynch syndrome in patients with colorectal cancer (CRC) than traditional...
17 years of research by more than 30,000 people tell you the dangers of eating red meat
The latest shows that a diet without red meat significantly reduces the risk of colon cancer in British women. Researchers at the University of Leeds evaluated...
This method can reduce the risk of bowel cancer death by up to 72%
“About 5-6 years ago, we started to see some young patients with colorectal cancer, including some people in their 20s or 30s, which had never been seen...
Colorectal cancer does not require complete chemotherapy after 6 months
According to the results of a unique global clinical trial study, some patients with stage III colon cancer who undergo surgical resection of their tumors and...
Video on best hospitals In India for lung cancer treatment
https://www.youtube.com/embed/9LluB6BFjVw Click the following link to discover more about best hospitals in India for lung cancer treatment please check out:...
Rare tumor should be guided after surgical resection
A study from the University of  Cincinnati School of Medicine at the Annual Cancer Symposium on Surgical Oncology in Chicago on March 24, 2018 showed that...
Genetic testing brings precise treatment to colorectal cancer
With the progress of society, many people’s living standards have improved, but due to work or family reasons they have ignored their own health...
Viagra daily small dose may reduce the risk of colorectal cancer
Scientists report that a small daily dose of Viagra can significantly reduce the risk of colorectal cancer in animal models, which is the third leading cause...
Incidence of rectal cancer among young people
In 2017, a study published in the Journal of the National Cancer Institute stated that among young people aged 20-50 years, the incidence of rectal cancer is ...
Colorectal cancer – A silent killer
It's important to detect and screen for colorectal cancer at early stage. With newer therapies and drugs, colorectal cancer can be treated at early...
Gastrointestinal cancer enters the era of precision medicine-genetic testing is the top priority
The FoundationOne CDx (F1CDx) cancer biomarker detection method was approved by the FDA in November 2017 to detect 324 different genes that can identify...
This radiotherapy combined with chemotherapy improves the survival rate of colorectal cancer
New research shows that in patients with liver or liver-dominant metastatic colorectal cancer , the addition of selective internal radiation therapy to...
Eating nuts may help colon cancer survive
According to the CALGB 8903 study published in the Journal of Clinical Oncology, patients with stage III colon cancer who eat at least 2 servings of nuts per...
How intestinal bacteria change the activity of anticancer drugs
According to a study by the University College London (UCL) on how nematodes and microorganisms treat drugs and nutrients, the activity of anticancer drugs...
The inextricable link between a high cholesterol diet and colon cancer
In a study of mice, scientists from the University of California, Los Angeles, David Geffen School of Medicine found that raising cholesterol levels in animals...
Gastrointestinal cancer treatment side effects
Gastrointestinal adverse reactions are one of the most common side effects including radiotherapy, chemotherapy, targeting and other treatments. Most of the...
Japanese artificial intelligence system diagnoses colorectal cancer in 0.3 seconds
Japanese researchers have developed an artificial intelligence system that extends an endoscope with a magnification of 500 times into the patient ’s...
Antibiotics can effectively prevent intestinal cancer metastasis
Researchers from Harvard University found evidence in a new study that colon cancer cells carry certain bacteria when they metastasize to other organs in the...
People group with a high risk of colorectal cancer
What is the disease of rectal cancer? Colorectal cancer is one of the five most common cancers in the world. The other four types of cancer are lung cancer,...
Should I start colorectal cancer screening at 45?
A new study reported at the European Digestive Disease Week (UEG) shows that regardless of family history, colorectal cancer screening has doubled since the...
Can cholera vaccine reduce the risk of death in colorectal cancer patients?
A Swedish study showed that vaccination with cholera after diagnosis of colorectal cancer can reduce the risk of colorectal cancer-related death and all-cause...
Chronic liver disease increases the risk of colorectal cancer
A systematic review and me of Sakuraba and other reports from the University of Chicagota analysis results show that patients with chronic liver disease have a...
Nuclear drugs to target and eliminate colorectal cancer
Researchers at Memorial Sloan Kettering Cancer Center and the Massachusetts Institute of Technology have developed a new three-step system that uses nuclear...
Fiber intake reduces mortality in patients with non-metastatic colorectal cancer
Mingyang Song of Harvard Medical School and Massachusetts General Hospital reported that after diagnosis of non-metastatic colorectal cancer, ingesting more...
Adding SIRT to chemotherapy can improve survival in colorectal cancer
Colorectal cancer The researchers found that adding SIRT to chemotherapy can improve the survival rate of colorectal cancer New research shows that for...
Stages of colon cancer
TNM staging system One tool doctors use to describe cancer staging is the TNM system. Doctors use the results of diagnostic tests and scans to answer the...
American Mayo Clinic experts talk about the treatment of rectal cancer
Rectal cancer is cancer that occurs in the last few inches of the colon. This area is called the rectum. The main treatment for rectal cancer is surgery....
Eating nuts is associated with a higher survival rate of colon cancer
 The 2017 Annual Meeting of the American Society of Oncology (ASCO) will be held in Chicago on June 2, local time. At 12 noon on May 17, local time, ASCO held...
Treatment strategy for oligometastatic advanced colorectal cancer
The concept of oligometastasis was proposed by Hellman in 1995. He pointed out that the lesion refers to  some intermediate states between the localized...
Anti-PD-L1 immunotherapy combined with MEK inhibitor for metastatic colorectal cancer
At the 18th World Congress of Gastrointestinal Cancer, a phase I clinical study showed that anti-PD-L1 immunotherapy combined with MEK inhibitors can...
Application and evaluation of KRAS gene mutation method for colorectal cancer
Targeting drugs such as cetuximab and panitumumab have been widely used in clinic as effective therapeutic drugs for colorectal cancer. Clinical data show...
Lonsurf for the treatment of refractory metastatic colorectal cancer
Japanese pharmaceutical company Otsuka (Otsuka) recently received good news in the US regulatory aspects, FDA approved anti-cancer compound new drug Lo 3...
Leukemia treatment options
Because leukemia classification and prognosis stratification are complex, there is no one-size-fits-all treatment method, and it is necessary to combine...
Research progress in lymphoma
On June 17-20, 2015, the 13th International Lymphoma Conference was successfully held in Switzerland. 3700 representatives from 90 countries participated in...
MD Anderson cancer center treatment story of a leukemia patient
Eddle and Pearlie Saddler, as his wife Pearlie hopes, “enjoy a regular life” in their South Carolina town. When they rested, Saddlers volunteered...
PD-1 inhibitor immunotherapy for B cell lymphoma
A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online...
Study finds new ideas for leukemia treatment
A new study from McMaster University in Canada said that it has discovered a new treatment strategy for acute myeloid leukemia. By stimulating the production...
Peripheral T-cell lymphoma faces challenges
The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United States varies...
AstraZeneca targeted drug Acalabrutinib has a new way to treat chronic lymphocytic leukemia
Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and...
Pathogenesis and treatment of mature T cell tumors
Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently,...
Can obesity cause cancer?
Obesity not only runs counter to the aesthetics of people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI) is related...
Guideline for the treatment of mixed phenotype acute leukemia
A study conducted at the Los Angeles Children ’s Hospital is providing the best treatment for a rare invasive leukemia called mixed phenotype acute leukemia...
Treatment for advanced lymphoma
Yesterday, the US FDA announced the approval of Seattle Genetics’ antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy...
This anticancer drug still benefits after 5 years of treatment for leukemia
According to the results of a 5-year follow-up of the key PACE trial published in the Journal of Hematology, panatinib (Ponatinib, Iclusig) has maintained...
Drugs for lymphoma leukemia to treat brain tumors
New Cleveland Clinic research shows for the first time that FDA-approved ibrutinib (ibrutinib) for lymphoma and leukemia may also help treat the most common...
Leukemia-first-line bosutinib treatment is superior to imatinib
Bosutinib is a Src / Abl dual tyrosine kinase inhibitor approved for the treatment of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), or...
Lipid-lowering drugs are expected to assist in the treatment of leukemia
The latest research found that some statins can improve the efficacy of chemotherapy drugs used to treat blood cancer in mouse models. Statins are drugs that...
Can bone marrow fibrosis drugs induce lymphoma?
Bone marrow fibrosis is a rare chronic disease of bone marrow hematopoietic cells. They benefit from JAK2 inhibitor drugs: symptom relief, prolonged survival,...
Venetoclax therapy for leukemia
On June 8 , the US FDA approved Venetoclax ( VENCLEXTA , AbbVie Inc. and Genentech Inc. ) for patients with chronic lymphocytic leukemia ( CLL ) or small...
Lymphoma: Pembrolizumab treatment approved
On June 12-13, FDA approved two new indications for K drug, just the day before the K drug was approved for the treatment of cervical cancer. One day later,...
Researchers discover a new mechanism of lymphoma resistance
In the United States, more than 70,000 people are diagnosed with non-Hodgkin’s lymphoma each year, which is caused by excessive proliferation of immune...
Progress in lymphoma immunotherapy
In recent years, the effect of immune checkpoint inhibitors on the treatment of Hodgkin’s lymphoma (HL) is impressive, but the disease still needs to be...
Genetic research solves 30-year leukemia mystery
Researchers at the University of California, San Francisco and St. Jude Children ’s Research Hospital in Tennessee have solved medical mysteries decades ago,...
Leukemia drug recognized by FDA as a breakthrough therapy
The FDA has granted its breakthrough drug quizartinib a breakthrough treatment. Quizartinib is a FLT3 inhibitor under investigation for the...
FDA updates medication regimen for chronic lymphocytic leukemia
The US Food and Drug Administration approved Venetoclax (Venclexta) combined with rituximab (VenR) for the treatment of patients with chronic lymphocytic...
The combination of two monoclonal antibodies for the treatment of lymphoma is 50% effective
According to a multi-center clinical trial led by researchers at the Stanford University School of Medicine, a new type of immunotherapy seems to be safe for...
Chemotherapy and immunotherapy combination for the treatment of leukemia
According to the results of the second phase of the study, the combination of standard-care chemotherapy drug azacitidine and the immune checkpoint inhibitor...
FDA approves first rituximab biosimilar to treat lymphoma
On November 28, FDA approved the first rituximab (Rituxan, rituximab) biosimilar, Truxima (rituximab-abbs, Celltrion Inc.) for non-Hodgkin’s lymphoma...
The first monotherapy for leukemia received FDA approval
The US FDA has approved gilteritinib ( Xospata ) for the treatment of adult patients with FLT3 mutation-positive relapse or...
Compared with chemotherapy and immunization, ibrutinib is more effective in treating elderly leukemia
The results of a multi-center phase III clinical trial showed that if elderly patients with chronic lymphocytic leukemia ( CLL ) are...
Combination therapy for the treatment of leukemia
Venetoclax (Venclexta) and rituximab (Rituxan) are used in combination with relapsed / refractory chronic lymphocytic leukemia ( CLL ), resulting in a...
New regimen for patients with lymphoma prolongs PFS by up to 28 months
12 Yue 3 days, a study “The Lancet” published online, for CD30 -positive outer peripheral T -cell lymphoma patients, this rituximab,...
Be alert to early symptoms of leukemia and keep children away from threats
Leukemia In the clinical field of medicine, leukemia is also called blood cancer and belongs to the category of malignant tumors. It is mainly divided into two...
Lymphoma prevention requires attention to these symptoms
Lymphoma Many people think that their body resistance is high, and think that malignant tumors such as lymphoma are still far away from us. In fact, in recent...
Why do young people have a high incidence of lymphoma?
Lymph People have very little knowledge of lymph. The neck, groin, and armpits are all lymph. If there is a problem with the lymphatic system, the body’s...
Leukemia and sepsis are different, they are not the same thing
People who know nothing about leukemia are the most frightened. They will definitely mix sepsis and leukemia. They think this is a disease. In fact, these are...
Wrong understanding of lymphoma will bring irreparable loss of life
Lymph Lymph is distributed throughout the body and is intricate. Generally speaking, the first thing people think of is the neck. In fact, there are both...
What are the targeted drugs for lymphoma?
Lymphoma The lymph in the human body is actually complicated. Lymphoma is the fastest and the highest death in malignant tumors, because the lymphatic system...
Lusotinib approved by the FDA for the treatment of myelofibrosis
Rusotinib tablets (ruxolitinib / Jakafi) for the treatment of bone marrow fibrosis with moderate or high risk, including primary bone marrow fibrosis,...
T cell-acute lymphocytic leukemia molecular genetic changes and new advances in targeted therapy
T cell- acute lymphocytic leukemia (T-ALL) T cell- acute lymphocytic leukemia (T-ALL) is a highly progressive malignant hematological tumor with a poor...
Another cancer vaccine has shown results in canine osteosarcoma
Scientists at Michigan State University are designing a virus-like particle called Qβ, which will generate an anti-cancer immune response in the body and may...
Bariatric surgery can reduce the risk of melanoma
In addition to rapid and lasting weight loss and other health benefits, bariatric surgery is now associated with a 61% reduced risk of malignant melanoma,...
A new method for treating rare sarcoma
Scientists at Trinity College Dublin (TCD) have developed a new therapy that can help treat the most common rare soft tissue sarcoma affecting young...
Olaratumab drug for soft tissue sarcoma
On October 19, 2016, the new drug Olaratumab passed the accelerated approval of the US FDA and could be combined with doxorubicin to treat specific types of...
A new strategy for immunotherapy of multiple myeloma
In recent decades, monoclonal antibody-based cancer treatment has been established as one of the most successful treatment strategies for solid tumors and...
Irebrin is better than dacarbazine in the posterior line of advanced liposarcoma
George D. Demetri and others from the American Dana Fabre / Briegen and Women ’s Hospital Cancer Center reported that among patients with liposarcoma, the...
Sarcoma drugs pazopanib, trabectedin, and eribulin
What is sarcoma? Sarcoma is a rare connective tissue tumor, so sarcoma can invade any part of our body. These tumors include liposarcoma, neurosarcoma,...
Proton successfully treats pediatric patients with rhabdomyosarcoma
In September 2015, a child patient with rhabdomyosarcoma in Guangdong, China successfully completed proton radiotherapy at the Proton Center of the Eastern...
U.S. cancer genetic testing successfully treats soft tissue sarcoma
On July 10, 2015, the National Cancer Institute (NCI) announced that the largest precision medicine clinical trial in history has begun to recruit patients....
Palbociclib for the treatment of sarcoma
Sarcoma, which occurs in young people and is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly...
Non-invasive treatment of sarcoma
Precise radiotherapy is the most important method of cancer treatment. Precise radiotherapy techniques represented by rapid front knife, proton knife, heavy...
Latest treatment option in uterine cancer
According to the latest report from the US Centers for Disease Control and Prevention (CDC), the incidence of almost all cancers has declined in the past two...
Avoid these things to avoid cervical cancer
With the continuous improvement of living standards, the age of people’s sexual organ development also continues to decrease. More and more people have...
Cervical cancer myths and misunderstandings
Everyday I will hear that cervical erosion will become cancerous when it is severe. In fact, not all of them will become cancerous. It can only be said that...
What is the progress of immunotherapy for gynecological tumors?
In recent years, the incidence of gynecological tumors has increased year by year, making the terms cervical cancer and ovarian cancer no longer unfamiliar to...
How to treat uterine cancer?
Uterine cancer According to the latest report from the US Centers for Disease Control and Prevention (CDC), the incidence of almost all cancers has declined in...
Strategy for cervical cancer screening
Since the 1960s, due to the popularity of screening, cervical cancer deaths have declined significantly. In the United States, cervical cancer is the 18th...
Research reports that 90% of cancers are caused by unhealthy lifestyle habits
Medical experts say that 90% of cancer patients are caused by unhealthy life habits, not DNA plays a leading role. Diet, sunlight, smoking, and disease have a...
The study found that cervical cancer may be caused by an imbalance of vaginal bacteria
Almost all cervical cancers are caused by human papillomavirus (HPV), which is called the “common cold” of sexually transmitted infections, because...
Cervical cancer treatment also has immunotherapy
Immunotherapy has brought promising breakthroughs to several types of cancer. Cervical cancer has a relatively large number of mutations (gene changes), which...
Pap smears are used for purposes other than cervical cancer screening
Pap smears can help reduce the incidence of cervical cancer. A new study shows that they can also be used to detect other gynecological cancers early. The...
Both men and women should understand cervical cancer
Although more than 12,000 women in the United States are diagnosed with cervical cancer every year and about 4,000 people die of cervical cancer, cervical...
Preventing cervical cancer
The FDA says that although cervical cancer kills about 4,000 women in the United States each year, most cervical cancers are preventable. Moreover, if the...
Do cervical precancerous lesions need immediate treatment?
For moderate cervical lesions-abnormal cells on the surface of the cervix (commonly called cervical intraepithelial neoplasia grade 2 or CIN2), routine...
How important is cervical cancer screening in women during pregnancy?
1. The importance of cervical cancer screening in women during pregnancy Juvenile laryngeal papilloma is more common in children and adolescents, mainly...
Advanced cervical cancer chemotherapy combined with bevacizumab has certain advantages
Studies reported by the University of California, Tewari et al. Showed that with the extension of follow-up time, the overall survival curves of patients in...
Can cervical cancer screening be done every 5 years?
Screening of cervical cancer Is it safe to extend the screening interval to 5 years or more after a negative screening result? A new study shows that the risk...
5 things to know about cervical cancer
Cancer experts at the City of Hope, California Center for Cancer Therapy and Research, said that in fact, the more women know about the disease, the greater...
IUD may greatly reduce the risk of cervical cancer
One of the longest-lasting female contraceptive methods and one of the best methods may provide unexpected health benefits for women using this method. A new...
Three abnormalities in the body are signs of cervical cancer
Cervicitis is a very common gynecological disease, and many people begin to worry after diagnosis of cervicitis: Will cervicitis worsen into cervical...
Vaccine for cervical cancer
Is there an age limit for vaccinating cervical cancer? The first approved HPV vaccine for preventing cervical cancer was officially launched in the market....
What are the characteristics of cervical cancer?
Cervical cancer Chronic cervicitis is more common than after delivery, miscarriage or surgical injury to the cervix, pathogens (mainly staphylococcus,...
How to treat women with condyloma acuminatum?
Treatment of condyloma acuminatum 1. Cryotherapy: Using freezing method can make the condyloma acuminatum freeze, forming a local high degree of edema of the...
How to treat female genital warts with the laser?
Condyloma acuminatum disease is a very contagious disease, and the common site of this disease is around the genitals, and this part is often more fragile,...
Matters needing attention in the treatment of condyloma acuminatum
Condyloma acuminatum What should I pay attention to during the treatment of genital warts? Condyloma acuminatum is a relatively serious sexually transmitted...
The safety and effectiveness of olaparib combined with carboplatin in the treatment of triple-negative breast and ovarian cancer
Victoria L. Chiou, an oncologist at the National Cancer Institute ’s Women ’s Malignancies Department, reported a phase I trial at AACR2015. The results...
HPV infection, genital tract inflammation, and cervical cancer
Cervical cancer According to the statistics of the World Health Organization in 2012, there are nearly 530,000 new cases of cervical cancer worldwide each...
Juvenile obesity is associated with increased risk of pancreatic cancer
Adolescent obesity is associated with many health problems in later life, and a large Israeli study has shown that the increased risk of fatal pancreatic...
A breast cancer drug may be used to treat pancreatic cancer
The survival rate of pancreatic cancer is very low. In the past 40 years, the survival rate has not changed significantly. Finding effective treatments is an...
Scientists reveal the best way to treat pancreatic cancer
Specific molecular signals released by pancreatic cancer cells have been determined. Pancreatic cancer is usually detected after the disease has spread, and...
New adjuvant therapy for pancreatic cancer comes out
In a recent interview, Dr. Afsaneh Barzi, assistant professor of clinical medicine at the University of Southern California Norris Comprehensive Cancer Center,...
The discovery of new protein helps the treatment and prevention of pancreatic cancer
New research has found that pancreatic cancer cells rely heavily on a protein to grow and spread. The research results can bring new treatment and prevention...
Gene mutation can increase women's risk of pancreatic cancer
A recent study published in the journal Cellular and Molecular Gastroenterology and Hepatology showed that a gene mutation called ATRX may lead to an increased...
Nobel Prize winner died of pancreatic cancer
Dr. Thomas A. Steitz died on October 9, 2018 at the age of 78, and died of pancreatic cancer. Steitz is the co-winner of the 2009 Nobel Prize in Chemistry....
New drugs for the treatment of pancreatic cancer
Ruiwen Zhang and Robert L. Boblitt from the University of Houston have developed a new pancreatic cancer drug. The research was published in the Journal of...
Folic acid and vitamin B6 may prevent pancreatic cancer
A recent study published in the European Journal of Clinical Nutrition showed that diet may play a key role in preventing pancreatic cancer. The study...
How to treat unresectable pancreatic neuroendocrine tumors?
Pancreatic neuroendocrine tumors (NETs) usually grow slowly, and the laboratory monitors the tumor for signs of growth through imaging tests. Patients with...
How to control pain in patients with pancreatic cancer?
Pancreatic cancer can invade and press nerves near the pancreas, which may cause abdominal or back pain in patients with pancreatic cancer. Pain specialists...
Mental health and psychosocial considerations during the COVID-19 outbreak – WHO guidelines
18 March 2020 In January 2020 the World Health Organization (WHO) declared the outbreak of a new coronavirus disease, COVID-19, to be a Public Health Emergency...
Killer cell immunotherapy can treat advanced pancreatic cancer
Researchers at the University of New South Wales in Sydney and the California Institute of Biomedicine (CALIBR) have demonstrated that “specially...
Signs of pancreatic cancer
The pancreas is located in the abdomen, behind the lower stomach. The pancreas releases enzymes that help the body digest food, and it also releases hormones...
Hot and cold pancreatic cancer tumors
A research team from the Abramson Cancer Center (ACC) at the University of Pennsylvania School of Medicine found that whether a tumor is hot or cold is...
Why is the mortality rate of pancreatic cancer is soo high?
The pancreas is an oblong organ located deep in the abdomen and is a component of the digestive system and endocrine system. It secretes hormones to regulate...
Proton therapy in pancreatic cancer
Pancreatic cancer Pancreatic cancer, also known as the king of cancer, is one of the common malignant tumors of the digestive system. In recent years, both...
Chemotherapy that prolongs the life of pancreatic cancer patient up to 20 months
At the 2018 ASCO conference, the results of a study on chemotherapy attracted a lot of attention. Studies have shown that an innovative chemotherapy can...
The high risk of pancreatic cancer is originally related to these 5 new gene changes
In the largest genome-wide pancreatic cancer study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute and...
New biomarker combination may accurately diagnose pancreatic cancer
Research reported by researchers at Fudan University shows that a new combination of four protein biomarkers can accurately diagnose pancreatic cancer. (Br J...
Targeted mass spectrometry can identify benign and malignant pancreatic cysts
According to Jabbar et al. Of the University of Gothenburg in Sweden, targeted mass spectrometry based on only three biomarkers of cyst fluid can highly...
Low-fat diet reduces female pancreatic cancer risk
Investigative research suggests that diet may affect the risk of pancreatic cancer. The study investigated the effect of a low-fat diet on the incidence of...
Five classic signs of pancreatic cancer
Pancreatic cancer is a malignant tumor with extremely high degree of harm, and pancreatic cancer will have different signs at different periods. Although...
Focus on diagnosis and treatment of pancreatic cancer
Pancreatic cancer: diagnosis If the doctor suspects that someone has pancreatic cancer, he will first ask the patient’s medical history, family medical...
Treatment of pancreatic cancer metastasized to the liver – A case study
In the fall of 2015, 44-year-old Doron Broman was diagnosed with pancreatic cancer -and was surprised to find that his pancreatic cancer had metastasized to...
New hope for the treatment of pancreatic cancer
Early diagnosis of pancreatic cancer is difficult and lacks specific drugs. Recently, researchers from France and Spain have discovered that a substance...
Diabetes and pancreatic cancer
Pancreatic cancer   Pancreatic cancer is a malignant tumor of the digestive tract that is highly malignant and difficult to diagnose and treat. About 90% is...
New technologies for pancreatic cancer treatment
Pancreatic cancer is a malignant tumor of the digestive tract that is highly malignant and difficult to diagnose and treat. It is hailed as the “king of...
Nanoparticle therapy can significantly slow down the growth rate of pancreatic tumors
Pancreatic cancer is currently one of the most deadly and chemotherapy-resistant cancers. Recently, cancer researchers in Australia have developed a very...
Pancreatic cancer drug olaparib received FDA expert support
Pancreatic cancer targeted drug, pancreatic cancer BRCA mutation targeted drug olaparib (Olaparib, Liprot Lynparza) received FDA expert support Due to the...
Guidelines for diagnosis and treatment of pancreatic cancer
Pancreatic Cancer According to statistics in 2014, the estimated number of new cases of pancreatic cancer in developed countries (the United States) is ranked...
What are the targeted drugs for gastric adenocarcinoma?
Gastric adenocarcinoma is also a relatively common type of cancer, and its incidence is relatively high in China. There are many ways to treat gastric...
Handling side effects of gastric cancer chemotherapy
Gastric cancer & chemotherapy Chemotherapy is also one of the commonly used treatment methods for malignant tumors in the clinic. After chemotherapy, there...
Understanding signals of gastric cancer
Food taken by the human body will enter the small intestine area through the throat, and then digest and absorb through the small intestine and the large...
Speed knife technology for the treatment of gastric cancer
Due to the long-term irregular diet or love to eat spicy and irritating food, many young people are faced with gastroenteritis. If left unattended, it will...
Targeted therapy for gastric cancer is guided by genetic testing
Genetic testing for gastric cancer After nearly ten years of development, tumor genetic testing has become the immediate need of a large number of cancer...
Gastric cancer drugs in 2020
Gastric cancer is growing Gastric cancer remains one of the most common and deadly cancers worldwide, especially among older males. Based on GLOBOCAN 2018...
Studies confirm the relation between gastritis and gastric cancer
Gastritis and gastric cancer Severe inflammation in certain tissues and organs of the body is usually related to the occurrence of cancer, but the mechanism of...
Gastric cancer and colorectal cancer have something in common
Researchers at the Duke University Cancer Institute have found that H. pylori may lead to an increased risk of colorectal cancer, especially for people with...
Choice of the right drug for treatment of gastric cancer
In addition to surgery, chemotherapy is the main treatment for gastric cancer At present, the treatment of gastric cancer is still mainly surgical...
Radioactive drugs approved for the treatment of gastric cancer and pancreatic cancer
Lutathera (Lutetium 177) is the first radiopharmaceutical approved by the FDA for the treatment of certain gastrointestinal and pancreatic cancers. Every...
Genomic technology predicts gastric cancer risk
A research team led by the National University Health System (NUHS) and Duke University School of Medicine used genomic technology to better understand...
Gastric cancer immunotherapy is still being explored
Gastric cancer immunotherapy is still an exciting research area, especially the pd-1 inhibitors pembrolizumab (Keytruda) and nivolumab (Nivolumab, Opdivo). In...
How did Japan reduce the incidence and death of gastric cancer?
It is not difficult to reduce the mortality rate of gastric cancer in a certain year, but it is difficult to continuously reduce it for 60 years. What did...
How to choose targeted therapy for gastric cancer patients?
Gastric cancer has no good targeted drugs in the past, all relying on cytotoxic drugs that “kill the enemy by a thousand and damage by 800”, which...
Continuously taking these medicines may double the risk of stomach cancer
A study published in “Intestine” showed that long-term use of proton pump inhibitors will double the risk of gastric cancer . Proton pump...
Eating habits that may cause stomach cancer
Related studies have found that patients with gastric cancer have obvious family aggregation: the first-degree relatives (ie parents and siblings) of gastric...
D2 radical surgery for gastric cancer or excision of discarded omentum sac
The anterior lobe of the transverse colon and the pancreatic capsule and the serous membrane of the stomach originate from the same germ layer, and together...